Skip to main content
. 2023 Mar 16;13(4):1053–1068. doi: 10.1007/s13555-023-00910-6

Fig. 2.

Fig. 2

Time to discontinuation based on therapy exposure gap of more than 2× per-label dosing frequency or mode of days of supply for each cohort. CI confidence interval; KM Kaplan–Meier. Notes: (1) Patients at risk of having the event are patients who have not had the event and have not been lost to follow-up at that point in time